Bruker Executive and Leadership Team

Frank Laukien, the Chairman, President & Chief Executive Officer at Bruker, directs the overarching corporate strategy and operational execution across all business segments. Laukien guides the company's expansion in scientific instrumentation, analytical technologies, and diagnostic solutions, ensuring alignment with market demands and technological advancements. This leadership role involves setting the vision for Bruker's comprehensive portfolio, which spans magnetic resonance, mass spectrometry, and advanced microscopy systems. By fostering innovation, Laukien drives the development of new instruments and technologies that support customers in pharmaceuticals, biotechnology, diagnostics, and academic research. The Chairman, President & Chief Executive Officer also oversees global market penetration and strategic partnerships, solidifying Bruker's position as a leader in scientific instrumentation. Frank Laukien's strategic direction ensures the company's sustained growth and impact on scientific discovery worldwide.

Jonathan Nunez, the Chief Financial Officer at Bruker, manages the company's financial operations and strategic fiscal planning. Nunez oversees all aspects of financial reporting, budgeting, and capital allocation, ensuring robust financial health across Bruker's global operations. This critical role involves optimizing financial performance and supporting strategic initiatives that drive revenue growth and operational efficiency. The Chief Financial Officer works closely with divisional leaders to manage financial resources effectively, supporting the company's extensive portfolio of scientific instrumentation and diagnostic solutions. Nunez's expertise is vital in navigating complex financial markets and ensuring sustainable profitability. By implementing sound financial strategies, Jonathan Nunez directly contributes to Bruker's ability to invest in research and development and expand its market reach.

Gerald Herman, the Executive VP & Chief Financial Officer at Bruker, provides executive leadership for the company's financial strategy and management. Herman collaborates with the Chief Financial Officer to ensure comprehensive financial oversight and strategic resource deployment across Bruker's diverse business segments. This position involves guiding financial planning, risk management, and investment strategies to support the company's global expansion in scientific instrumentation and analytical technologies. The Executive VP & Chief Financial Officer plays a key part in optimizing financial structures and driving shareholder value. Herman's leadership ensures that financial operations are aligned with Bruker's mission to deliver advanced solutions to research, industry, and government clients. Gerald Herman's financial acumen is integral to maintaining the company's strong market position and facilitating future growth.

Wulf Jung, the President PCI Division at Bruker, directs the strategic operations and market development for the Particle Characterization and Separation (PCI) division. Jung oversees the innovation and delivery of advanced analytical instruments within this segment, focusing on technologies that serve industries such as pharmaceuticals, materials science, and environmental testing. This leadership role involves driving product development, enhancing customer support, and expanding market share for PCI solutions globally. The President PCI Division works to ensure that the division's offerings, including spectroscopy and microscopy systems, meet the evolving needs of scientific research and industrial applications. Wulf Jung's focus on operational excellence and technological advancement strengthens Bruker's position in specialized analytical markets.

Mark Munch, the President, Bruker BNANO Group at Bruker, leads the strategic direction and operational execution for the Nano Surfaces and Advanced Materials division. Munch oversees the development and commercialization of cutting-edge instrumentation in areas such as atomic force microscopy, X-ray microscopy, and semiconductor metrology. This leadership position involves driving innovation in nanoscale analysis and materials characterization, supporting advancements in semiconductors, life sciences, and advanced manufacturing. The President, Bruker BNANO Group ensures that the division's comprehensive portfolio of high-performance systems meets the rigorous demands of global research and industrial clients. Mark Munch's strategic oversight is crucial for expanding Bruker's technological leadership in nanoscale science and materials analysis.